Publications

Host proteins associated with strong neutralising SARS-CoV-2 antibody responses in a South African cohort

Commun Med

This study looked at why some people develop stronger protection against COVID-19 than others. The researchers focused on a group of people in South Africa who had been infected and examined their blood to understand what was linked to a strong immune response. 

They found that certain proteins in the body were connected to higher levels of protective antibodies. These proteins are involved in how the body detects infection, sends signals between cells, and controls inflammation. People with stronger antibody responses tended to have higher levels of proteins that help the immune system respond quickly and effectively to the virus. 

The study also showed that the balance of the immune response matters. A well-regulated response —where the body fights the virus without causing too much inflammation — was linked to better protection. On the other hand, weaker antibody responses were associated with fewer of these helpful proteins or less coordinated immune activity. 

Overall, the findings suggest that it is not just the virus itself that determines how well someone is protected, but also how their body responds at a deeper biological level. Understanding these patterns could help scientists improve vaccines and treatments by focusing on the factors that lead to stronger and longer-lasting protection against COVID-19. 

SANTHE is an Africa Health Research Institute (AHRI) flagship programme funded by the Science for Africa Foundation through the DELTAS Africa programme; the Gates Foundation; Gilead Sciences Inc.; and the Ragon Institute of Mass General, MIT, and Harvard.